Cipla Ltd on Wednesday (November 13) announced that the US Food and Drug Administration (US FDA) has issued eight observations following an inspection of the company’s manufacturing facility in ...

Cipla Ltd. announced on Wednesday that the company received eight observations from the US Food and Drug Administration for its manufacturing facility in Bengaluru. The FDA conducted an inspection at ...

Cipla's stock is priced at Rs 1553.80, reflecting a decrease of 2.44% for the day, while the one-week return stands at -1.53%. Cipla is currently trading at Rs 1560.30, showing a decline of 2.03% ...

Irrespective of how hard you train, you cannot build muscle until you’re consuming a balanced, protein-rich diet. Protein is the building block of muscle. Similarly, amino acids are the building ...

Cipla's shares closed at Rs 1594.05 today, reflecting a decrease of 0.45% in value. Cipla's stock is priced at Rs 1594.4, reflecting a slight decrease of 0.43% today, while maintaining a beta of 0.551 ...

Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York 10065, United States Tri-Institutional PhD Program in Chemical Biology, New York, New York 10065, ...

Cipla encountered resistance around the Rs 1,587 price level in the previous trading session, which corresponds to the 61.8 per cent Fibonacci retracement of its prior downtrend. This level is ...

Drugmaker Cipla expects to put the “slow seasonal growth” of its ‘One India’ business in the last quarter behind it, even as it looks to resolve supply issues involving its generic ...

Taurine is an amino acid concentrated in the brain, heart, eyes, and muscles. The body naturally produces taurine from the amino acid cysteine. Protein-rich foods like meat and seafood contain ...

Cipla Ltd.'s share price has added around 11% in three sessions of gains after US Food & Drug Administration tagged the company's Goa facility as 'voluntary action indicated'. This is an important ...

Shares of Cipla Ltd advanced 3 per cent in Monday's trade after the drugmaker announced a VAI status for its Goa unit, which had been battling a compliance challenge since 2019. The VAI status is ...